Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

ProtoKinetix, Incorporated PKTX OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
45/100
1/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

ProtoKinetix, Incorporated (PKTX) is a Biotechnology company in the Healthcare sector, currently trading at $0.01. It has a SharesGrow Score of 41/100, indicating a mixed investment profile with 1 out of 7 criteria passed.

Net income is $364,000 (loss), growing at +36.2%/yr. Net profit margin is 0% (thin). Gross margin is 0% (+0 pp trend).

Balance sheet: total debt is $0 against $342,090 equity (Debt-to-Equity (D/E) ratio 0, conservative). Current ratio is -0.03 (tight liquidity). Debt-to-assets is 0%. Total assets: $466,137.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 100/100 (Pass), Past 0/100 (Fail), Health 50/100 (Partial), Moat 28/100 (Fail), Future ?/100 (Fail), Income ?/100 (Fail).

PKTX SharesGrow Score Overview

59/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 100/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 50/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 28/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 0/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — PKTX

—
VALUE N/A
N/A
No analyst coverage available for this stock.
✓
GROWTH Pass
100/100
PKTX: +0%/yr revenue is, +36.2%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
~
HEALTH Partial
50/100
Balance sheet PKTX: Debt-to-Equity (D/E) ratio 0 (conservative), Current ratio is -0.03 (tight liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
28/100
PKTX: Gross margin is 0% (+0 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 28/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
—
INCOME N/A
N/A
No analyst coverage available for this stock.

Stock Chart & Stats

Market Data
52-Week Range0.004-0.0148
Volume185K
Avg Volume (30D)118.88K
Market Cap$2.74M
Beta (1Y)0.66
Share Statistics
EPS (TTM)0.00
Shares Outstanding$358.56M
IPO Date2002-04-22
CEOMichael Richard Guzzetta
Financial Highlights & Ratios
Gross Profit$-52.87K
EBITDA$-311K
Net Income$-364K
Operating Income$-311K
Total Cash$-4.7K
Net Debt$4.7K
Total Assets$466.14K
Price / Earnings (P/E)-7
Analyst Forecast
Company Info
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS7437221002

Price Chart

Track all markets on TradingView
PKTX
ProtoKinetix, Incorporated ↗  ·  Other OTC
Healthcare • Biotechnology
0.00 52WK RANGE 0.01

People Also View

NPHC
NPHC
Nutra Pharma Corp.
$0.00
+0.00%
 RSPI
RSPI
RespireRx Pharmaceuticals Inc.
$0.00
+0.00%
 NBIO
NBIO
Nascent Biotech, Inc.
$0.00
+0.00%
 RGRX
RGRX
RegeneRx Biopharmaceuticals, Inc.
$0.00
+0.00%
 MYMX
MYMX
Mymetics Corporation
$0.00
+0.00%
 LLY
LLY
Eli Lilly and Company
$905.13
-1.88%
 JNJ
JNJ
Johnson & Johnson
$238.67
-0.60%
 ABBV
ABBV
AbbVie Inc.
$208.43
-0.87%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message